Notes
The study was sponsored and funded by Sanofi Pasteur.
Reference
Chit A, et al. Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors. Vaccine : 11 Nov 2014. Available from: URL: http://doi.org/10.1016/j.vaccine.2014.10.079
Rights and permissions
About this article
Cite this article
High-dose trivalent influenza vaccine worth a shot in elderly. PharmacoEcon Outcomes News 718, 23 (2014). https://doi.org/10.1007/s40274-014-1788-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1788-9